clinical trials

News

Rare disease drug from LEO's Timber felled by failed study

Just a few months after buying Timber Pharma, LEO Pharma has revealed that the main drug it acquired as part of the deal has failed a phase 3 trial.

News

Lilly says tirzepatide staves off diabetes in phase 3 trial

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and ob

News

US govt taps Walgreens for decentralised trials

Retail pharmacy giant Walgreens has signed a five-year contract with the US government – worth up to $100 million – for access to its decentralised clinical trials (DCT) network.

News

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight.

News

Colourised transmission electron micrograph of mpox virus particles (red/yellow) found within infected VERO E6 cells (brown)

As WHO calls mpox emergency, NIH says only drug ineffective

The only antiviral recognised as an mpox treatment was unable to shorten the time to resolution of lesions in a trial in the Democratic Republic of the Congo (DRC), the epicentre of an outb

News

AI medtech specialist Firefly lists on Nasdaq after merger

Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligenc

Rare disease drug from LEO's Timber felled by failed study

Lilly says tirzepatide staves off diabetes in phase 3 trial

US govt taps Walgreens for decentralised trials

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

As WHO calls mpox emergency, NIH says only drug ineffective

AI medtech specialist Firefly lists on Nasdaq after merger

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

clinical trials

Editor's Picks